U S Global Investors Inc Eagle Pharmaceuticals, Inc. Transaction History

U S Global Investors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 04, 2020	SELL	$34.37 - $60.07 $646,156 - $1.13 Million	-18,800 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$54.32 - $64.31 $1.02 Million - $1.21 Million	18,800 New	18,800 $1.13 Million
Q2 2018 Aug 14, 2018	SELL	$51.25 - $76.62 $984,000 - $1.47 Million	-19,200 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$52.16 - $66.86 $1 Million - $1.28 Million	19,200 New	19,200 $1.01 Million
Q4 2017 Feb 13, 2018	SELL	$49.6 - $60.87 $624,960 - $766,962	-12,600 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$46.62 - $60.36 $60,606 - $78,468	-1,300 Reduced 9.35%	12,600 $751,000
Q2 2017 Aug 17, 2017	BUY	N/A	13,900	13,900 $1.1 Million

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $6.77M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of U S Global Investors Inc, based on Form 13F filings with the SEC.

Stay updated on U S Global Investors Inc with notifications on news.